Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)
Placebo comparator
Locations
1
France
Department of Cardiology AP-HP Hôpital européen Georges - Pompidou
Paris, France
Start Date
June 12, 2023
Primary Completion Date
October 12, 2026
Completion Date
October 12, 2026
Last Updated
December 19, 2025
NCT05949567
NCT06672237
NCT06261060
NCT07473960
NCT06057974
NCT07089121
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions